Raj, Ranjan, Aditya Kumar, Prachi Sood, Roshan Kumar, and Vinod Rana. 2023. “Randomized Phase III Trial Comparing Epirubicin/ Doxorubicin Plus Docetaxel and Epirubicin/ Doxorubicin Plus Paclitaxel As First Line Treatment in Women With Advanced Breast Cancer”. Journal for Research in Applied Sciences and Biotechnology 2 (3):55-63. https://doi.org/10.55544/jrasb.2.3.8.